Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATTITUD: Desloratadine Continuous vs PRN in CIU
NCT00783354Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of desloratadine in chronic idiopathic urticaria (CIU) (2 arms), sponsored by Organon & Co. Primary endpoint: Changes from Visit 2 to Visit 4 of Vq-derm questionnaire score and DLQI quality of life score at 2 months. Started Apr 2003; status: completed.
02
Drugs
desloratadine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT00783354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783354.